Infection Control in the Practice of Anesthesia
Infection Control in the Practice of Anesthesia, Videotape Number IS in the series cosponsored by the ASA, considers the prevention of infection in patients undergoing anesthesia, strategies for reducing occupational transmission of infection to practitioners, and the necessity for anesthetists to incorporate universal precautions in infection control. It addresses the procedural considerations for anesthesia concerning nosocomial infection, blood borne pathogens, airborne pathogens, contact pathogens and the awareness of HIV infection. David Cheney, M.D., an anesthesiologist, describes the danger to the anesthesia provider in telling his own experience with an accidental needlestick that led to his becoming HIV Positive.
The program consultants include: William P. Arnold, 111, M.D., Chairman, ASA Committee on Occupational Health of Operating Room Personnel; Arnold J. Berry, M.D., Chairman, ASA Infection Control Policy Task Force; Samuel C. Hughes, M.D., Mark P. Fritz, M.D., Members, ASA Infection Control Policy Task Force; Leon Helton, CRNA, Chairman, AANA Infection Control Task Force; Lynn Van Wormer, CRNA, Brent W. Sommers, CRNA, Members, AANA Infection Control Task Force; Darlene G. Homa, CRNA, Member AANA
The videotape was made possible by an educational grant from Burroughs Wellcome Company and will be available for distribution by them in late Fall. Arnold I. Berry, M.D., was producer and Mark P. Fritz, M.D., and Samuel C. Hughes, M.D., associate producers. Filming took place at Emory University Hospital, Atlanta, GA. GWF Associates, Holmdel, New Jersey, collaborated on scripting, technical development, and filming.
Central Venous Catheter Complications
Central Venous Catheter Complications, Videotape Number 17 comprising a three-part series, was developed to inform clinicians about the many possible complications associated with Central Venous Catheters (CVCs).
The first parts are directed toward individuals who place CVCs and have a need to review the anatomy, pathology and radiology. Later, the tape discusses CVC-related infection and peripherally implanted central lines, as well as home-care aspects of CVC placement and maintenance. The tape was funded and prepared under the direction of the Food and Drug Administration (FDA), several specialty societies and catheter manufacturers. Special recognition should go to the Central Venous Catheter Working Group for their efforts in the planning, preparation and completion of the project. Walter L. Scott, Ph.D., was the Project Director for the FDA and Anesthesiologist David M. Paulus, M.D., University of Florida College of Medicine, Gainesville, the chief Technical Consultant. The APSF acted as the financial holding organization. Segments of the three-part series were taped on location at: New England Deaconess Hospital, Boston, MA; Franklin Square Hospital Center, Baltimore, MD; University of Florida, Shands Hospital, Gainesville, FL; National Institutes of Health, Bethesda, MD; Uniformed Services University of the Health Sciences, Bethesda, MD; Food and Drug Administration, Rockville, MD.
There will be several modes of distribution, including 7,000 copies to -all hospital administrators in the United States. #or American anesthesia practitioners, Burroughs Wellcome Company will begin distribution to ‘anesthesia departments in January 1993 in the usual manner. In addition, copies are available to other parties from the National Audiovisual Center for approximately $90.00 a set.
Dr. Pierce, APSF President, is Executive Producer of the ASA Patient Safety Videotape Series.